CAPITAL & REGIONAL PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.94 GBX | +1.88% |
|
+1.88% | -11.56% |
| 04-24 | Calliditas Therapeutics AB Announces Positive NefIgArd Open Label Extension Results | CI |
| 04-22 | Capital & Regional picks Gerry Murphy as non-exec director | AN |
Evolution of the average Target Price on Capital & Regional plc
Price target over the last 5 years
History of analyst recommendation changes
a1705fc.hl2Kbgsb5ux79cBhfwfGZ7qXmfoPRr1v5Ni_Ern7BuE.3wq9KV5IjIEYk7E0RkOgCOP8y84-Cck9gIfgVfypNszRNsw-Onynuk2ygQ~4c0d7f787744e99807716cf9c429c63a
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5
GBP
Average target price
0.686
GBP
Spread / Average Target
+37.20%
High Price Target
0.75
GBP
Spread / Highest target
+50.00%
Low Price Target
0.6
GBP
Spread / Lowest Target
+20.00%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Capital & Regional plc
| Berenberg Bank |
Trading Rating
Investor Rating
ESG Refinitiv
B-
Annual profits - Rate of surprise
- Stock Market
- Equities
- CAL Stock
- Consensus Capital & Regional plc
